Wanjia Group Holdings Limited (HKG:0401)

Market Cap	130.92M +195.8%
Revenue (ttm)	165.39M +2.3%
Net Income	-9.86M
EPS	-0.01
Shares Out	1.13B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	225,640
Open	0.1140
Previous Close	0.1130
Day's Range	0.1130 - 0.1160
52-Week Range	0.0610 - 0.2090
Beta	1.34
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 29, 2026

About Wanjia Group Holdings

Wanjia Group Holdings Limited, an investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong. The company offers hemodialysis treatment and consultancy services. It sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloo...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2004
• Employees: 183
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0401

Financial Performance

In fiscal year 2026, Wanjia Group Holdings's revenue was 165.39 million, an increase of 2.28% compared to the previous year's 161.69 million. Losses were -9.86 million, 49.1% more than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error